FY2020 EPS Estimates for Orthofix International N.V. (OFIX) Increased by Analyst
Orthofix International N.V. (NASDAQ:OFIX) – Equities researchers at Gabelli boosted their FY2020 earnings per share estimates for Orthofix International N.V. in a research note issued on Wednesday. Gabelli analyst J. Tsai now forecasts that the medical device company will post earnings of $2.20 per share for the year, up from their prior forecast of $2.05.
OFIX has been the subject of a number of other reports. Zacks Investment Research upgraded Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a research note on Thursday, November 2nd. TheStreet downgraded Orthofix International N.V. from a “b” rating to a “c+” rating in a research note on Tuesday, October 31st. BTIG Research set a $56.00 price objective on Orthofix International N.V. and gave the stock a “buy” rating in a research note on Monday, October 30th. BidaskClub upgraded Orthofix International N.V. from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. Finally, Jefferies Group LLC restated a “buy” rating and set a $55.00 price objective (up from $50.00) on shares of Orthofix International N.V. in a research note on Thursday, August 10th. Seven investment analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and a consensus price target of $54.42.
Shares of Orthofix International N.V. (NASDAQ:OFIX) traded down $0.39 during midday trading on Monday, hitting $51.23. The stock had a trading volume of 121,310 shares, compared to its average volume of 160,616. Orthofix International N.V. has a 1-year low of $32.51 and a 1-year high of $54.33. The company has a market cap of $946.01, a P/E ratio of 33.92, a price-to-earnings-growth ratio of 2.57 and a beta of 0.15.
Orthofix International N.V. (NASDAQ:OFIX) last issued its quarterly earnings results on Monday, October 30th. The medical device company reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a return on equity of 10.26% and a net margin of 0.33%. The business had revenue of $105.30 million during the quarter, compared to the consensus estimate of $100.67 million. During the same period in the previous year, the business earned $0.36 EPS. The business’s quarterly revenue was up 6.9% on a year-over-year basis.
In related news, CEO Brad Mason sold 2,733 shares of the company’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $48.10, for a total transaction of $131,457.30. Following the completion of the transaction, the chief executive officer now directly owns 188,053 shares in the company, valued at approximately $9,045,349.30. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Rice Doug sold 7,353 shares of the company’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $49.46, for a total value of $363,679.38. Following the transaction, the chief financial officer now owns 44,743 shares of the company’s stock, valued at $2,212,988.78. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 23,406 shares of company stock valued at $1,138,531. 5.60% of the stock is owned by company insiders.
A number of hedge funds have recently made changes to their positions in OFIX. Pinebridge Investments L.P. boosted its position in Orthofix International N.V. by 2.3% during the 2nd quarter. Pinebridge Investments L.P. now owns 2,378 shares of the medical device company’s stock worth $111,000 after acquiring an additional 53 shares during the period. State of Alaska Department of Revenue boosted its position in Orthofix International N.V. by 79.3% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,551 shares of the medical device company’s stock worth $165,000 after acquiring an additional 1,571 shares during the period. Municipal Employees Retirement System of Michigan acquired a new position in Orthofix International N.V. during the 2nd quarter worth $196,000. UBS Asset Management Americas Inc. acquired a new position in Orthofix International N.V. during the 1st quarter worth $229,000. Finally, New York State Teachers Retirement System acquired a new position in Orthofix International N.V. during the 1st quarter worth $262,000. Institutional investors own 93.81% of the company’s stock.
About Orthofix International N.V.
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.